Discovery Laboratories Inc. (NASDAQ:WINT) was down 9.2% during mid-day trading on Monday . The stock traded as low as $2.60 and last traded at $2.65, with a volume of 149,553 shares traded. The stock had previously closed at $2.92.

WINT has been the subject of several research analyst reports. HC Wainwright restated a “buy” rating on shares of Discovery Laboratories in a research report on Friday, May 20th. Zacks Investment Research upgraded shares of Discovery Laboratories from a “hold” rating to a “buy” rating and set a $2.25 price target for the company in a research report on Thursday, June 23rd.

The firm has a 50-day moving average of $2.02 and a 200-day moving average of $2.19. The company’s market capitalization is $22.60 million.

Discovery Laboratories (NASDAQ:WINT) last posted its quarterly earnings data on Wednesday, August 10th. The company reported ($1.29) EPS for the quarter, beating analysts’ consensus estimates of ($1.64) by $0.35. Analysts forecast that Discovery Laboratories Inc. will post ($5.87) earnings per share for the current year.

Windtree Therapeutics, Inc, formerly Discovery Laboratories, Inc, is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.